These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 6506005

  • 1. [Evaluation of drug-induced hepatic complications collected by the French drug surveillance organization].
    Jean-Pastor MJ, Jouglard J.
    Therapie; 1984; 39(5):493-500. PubMed ID: 6506005
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Ticlopidine and hepatic adverse reactions. Data from the Spanish drug surveillance system].
    Carvajal García-Pando A, García Ortega P, Rueda de Castro AM, García del Pozo J.
    Med Clin (Barc); 1999 Apr 24; 112(14):557-8. PubMed ID: 10363248
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Environmental hepatic injury in man.
    Popper H, Gerber MA, Schaffner F, Selikoff IJ.
    Prog Liver Dis; 1979 Apr 24; 6():605-38. PubMed ID: 396574
    [No Abstract] [Full Text] [Related]

  • 7. [Postmarketing survey on the clinical use of cefotiam].
    Kitaguchi T, Ebi O.
    Jpn J Antibiot; 1983 Aug 24; 36(8):2029-52. PubMed ID: 6317911
    [Abstract] [Full Text] [Related]

  • 8. Adverse Drug Reactions Advisory Committee: ADRAC report for 1980.
    Med J Aust; 1982 May 15; 1(10):416-9. PubMed ID: 6808324
    [No Abstract] [Full Text] [Related]

  • 9. [Drug-induced liver disease: experiences of the Swiss Center for Adverse Drug Effects 1989-1991].
    Werth B, Kuhn M, Hartmann K, Kobler E, Reinhart WH.
    Schweiz Med Wochenschr; 1993 Jun 12; 123(23):1203-6. PubMed ID: 8327867
    [Abstract] [Full Text] [Related]

  • 10. [Hepatotoxicity of drugs. Update of a data bank of hepatic involvement and responsible drugs].
    Biour M, Poupon R, Grange JD, Chazouillères O, Levy VG, Bodin F, Cheymol G.
    Gastroenterol Clin Biol; 1990 Jun 12; 14(3):263-77. PubMed ID: 2344912
    [No Abstract] [Full Text] [Related]

  • 11. [Hepatotoxicity of drugs. Update of the data bank on hepatic involvement and the responsible drugs].
    Biour M, Poupon R, Calmus Y, Grange JD, Lévy VG, Bodin F, Cheymol G.
    Gastroenterol Clin Biol; 1989 Jan 12; 13(1):80-93. PubMed ID: 2925045
    [No Abstract] [Full Text] [Related]

  • 12. [Halothane hepatitis. Possibilities of prevention].
    Døssing M, Andreasen B, Ranek L, Johansen SH.
    Ugeskr Laeger; 1982 Feb 15; 144(7):466-8. PubMed ID: 7080249
    [No Abstract] [Full Text] [Related]

  • 13. [Hepatotoxicity of drugs. Update of a data bank of hepatic involvements and responsible drugs].
    Biour M, Poupon R, Calmus Y, Grangé JD, Hamel JD, Lévy VG, Bodin F, Cheymol G.
    Gastroenterol Clin Biol; 1988 Jan 15; 12(1):48-60. PubMed ID: 3350250
    [No Abstract] [Full Text] [Related]

  • 14. Rechallenge in drug-induced liver injury: the attractive hazard.
    Andrade RJ, Robles M, Lucena MI.
    Expert Opin Drug Saf; 2009 Nov 15; 8(6):709-14. PubMed ID: 19968572
    [Abstract] [Full Text] [Related]

  • 15. Adverse drug reactions in children.
    Fiechtner H.
    S D J Med; 1994 Sep 15; 47(9):325. PubMed ID: 7973598
    [No Abstract] [Full Text] [Related]

  • 16. [Drug-induced liver damage].
    Holm-Bentzen M, Almbjerg F, Ranek L.
    Ugeskr Laeger; 1981 May 04; 143(19):1213-6. PubMed ID: 7303182
    [No Abstract] [Full Text] [Related]

  • 17. Adverse drug reactions: part II.
    Wooten JM.
    South Med J; 2010 Nov 04; 103(11):1138-45; quiz 1146-7. PubMed ID: 20890249
    [Abstract] [Full Text] [Related]

  • 18. [Drug-induced hepatic involvement, something to consider!].
    Oestreicher MK, Desmeules J, Giostra E, Gross B, Hadengue A, Dayer P.
    Schweiz Med Wochenschr; 1996 Nov 30; 126(48):2094-6. PubMed ID: 8992632
    [Abstract] [Full Text] [Related]

  • 19. [Methodology of epidemiological studies in drug hepatotoxicity].
    Plomteux G.
    Sem Hop; 1974 Jun 30; 50(28):1947-52. PubMed ID: 4374747
    [No Abstract] [Full Text] [Related]

  • 20. Postmarketing surveillance on side-effects of cefminox sodium (Meicelin).
    Mayama T, Koyama Y, Sebata K, Tanaka Y, Shirai S, Sakai H.
    Int J Clin Pharmacol Ther; 1995 Mar 30; 33(3):149-55. PubMed ID: 7599913
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.